Clinical trial
Transplantation of Autologous Purified Bone Marrow Derived Specific Populations of Stem Cells and Mesenchymal Stem Cells in Patients With Rheumatoid Arthritis
NCT03067870 is registered in ClinicalTrials.gov with Stem Cells Arabia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transplantation of Autologous Purified Bone Marrow Derived Specific Populations of Stem Cells and Mesenchymal Stem Cells in Patients With Rheumatoid Arthritis
- Lead sponsor
- Stem Cells Arabia
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- November 30, 2016
- Completion date
- February 28, 2022
- Enrollment
- 100 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
osteoarthritis, hip, osteoarthritis, knee, rheumatoid arthritis